Total revenue increased 11% to $133.5 million
Net income of $16.1
million at a 12% margin; adjusted EBITDA increased to
$50.6 million at a 38%
margin
NEW
YORK, Nov. 12, 2024 /PRNewswire/ -- Integral Ad
Science Holding Corp. (Nasdaq: IAS), a leading global media
measurement and optimization platform, today announced financial
results for the third quarter ended September 30, 2024.
"We increased revenue at a double-digit rate in the third
quarter, driven by our industry-leading products and the
contribution from new customers, with strong adjusted EBITDA
performance," said Lisa
Utzschneider, CEO of IAS. "We are excited about several new
logo wins and the C-level executives we have added to our team. Our
focus remains on driving product innovation and leveraging AI to
deliver superior value for our customers. We were delighted to
announce our first-to-market optimization solution for Meta in
October."
Third Quarter 2024 Financial Highlights
- Total revenue was $133.5
million, an 11% increase compared to $120.3 million in the prior-year period.
- Optimization revenue was $61.1
million, a 7% increase compared to $57.0 million in the prior-year period.
- Measurement revenue was $52.9
million, an 11% increase compared to $47.8 million in the prior-year period.
- Publisher revenue was $19.5
million, a 26% increase compared to $15.5 million in the prior-year period.
- International revenue, excluding the Americas, was
$40.8 million, an 11% increase
compared to $36.9 million in the
prior-year period, or 31% of total revenue for the third quarter of
2024.
- Gross profit was $106.2
million, a 12% increase compared to $94.7 million in the prior-year period. Gross
profit margin was 80% for the third quarter of 2024.
- Net income was $16.1
million, or $0.10 per share,
compared to a net loss of $13.7
million, or $0.09 per share,
in the prior-year period. Net income margin was 12% for the third
quarter of 2024.
- Adjusted EBITDA* was $50.6
million, a 25% increase compared to $40.6 million in the prior-year period. Adjusted
EBITDA* margin was 38% for the third quarter of 2024.
- Cash and cash equivalents were $57.1 million at September
30, 2024.
Recent Business Highlights
- C-Level Appointments - In September, IAS announced that
Marc Grabowski was appointed as
Chief Operating Officer from his previous role as Global VP of
Oracle Advertising. Srishti Gupta
joined as Chief Product Officer from Rokt where she served as Chief
Product Officer. She was previously Director of Ads Measurement at
Amazon.
- First-to-Market Meta Optimization Solution - In October,
IAS announced the testing of first-to-market availability pre-bid
optimization solutions for IAS's current advertisers on Meta.
Social Optimization for Content Block Lists enable advertisers to
ensure that better impressions are delivered to brand suitable ad
adjacencies. This solution empowers advertisers with proactive
pre-screen capabilities at the content level on Facebook and
Instagram.
- TikTok Partnership Expansion - In October, IAS expanded
its Total Media Quality (TMQ) offering for TikTok to include
viewability, invalid traffic, and brand safety and suitability
measurement for advertisers across TikTok's newly available ad
placements within the Profile, Search, Following Feeds and TikTok
Lite.
- Misinformation Detection Launch on YouTube - In
September, IAS announced the expansion of its TMQ offering on
YouTube to include its industry-aligned misinformation brand safety
and suitability reporting for advertisers running campaigns across
YouTube ad inventory. IAS can now detect content across YouTube
that it identifies as misinformation, enabling advertisers to
further verify the safety and suitability of their digital media
investments on YouTube.
- Google Ad Manager Partnership - In November, IAS
announced the launch of IAS Curation with Google Ad Manager. IAS
now offers programmatic buyers a deal-based enrichment pathway
designed to curate inventory at the source. IAS Curation empowers
advertisers with actionable data to activate avoidance and
contextual targeting strategies across media buys at scale for
Google Ad Manager.
- Quality Attention Expansion to Publishers and SSPs - In
October, IAS announced the availability of Quality Attention for
publishers and sell-side platforms (SSPs). IAS's Quality Attention
metrics and scores, previously available only to advertisers, help
publishers improve yield optimization and drive revenue
opportunities.
Financial Outlook
"We reported revenue growth of 11% and an adjusted EBITDA margin
of 38% for the period," said Tania
Secor, CFO of IAS. "With healthy cash flows and low debt, we
will continue to invest in the business to support our growth. Our
updated financial outlook for the full year reflects our third
quarter performance and anticipated advertising demand in the
fourth quarter."
IAS is providing the following financial outlook for the fourth
quarter of 2024 and updating its full year 2024 revenue and
adjusted EBITDA outlook:
Fourth Quarter Ending December 31,
2024:
- Total revenue of $148
million to $150 million
- Adjusted EBITDA* of $55
million to $57 million
Year Ending December 31,
2024:
- Total revenue of $525
million to $527 million
- Adjusted EBITDA* of $185
million to $187 million
* See "Supplemental Disclosure Regarding Non-GAAP Financial
Information" section herein for an explanation of these measures.
IAS is unable to provide a reconciliation for forward-looking
guidance of adjusted EBITDA and corresponding margin to net income
(loss), the most closely comparable GAAP measures without
unreasonable effort, because certain material reconciling items,
such as depreciation and amortization, interest expense, income tax
expense (benefit) and acquisition, restructuring and integration
expenses, cannot be estimated due to factors outside of IAS's
control and could have a material impact on the reported results.
However, IAS estimates stock-based compensation expense for the
fourth quarter of 2024 in the range of $15
million to $16 million and for
the full year 2024 in the range of $62
million to $63 million.
INTEGRAL AD SCIENCE
HOLDING CORP.
|
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
(UNAUDITED)
|
|
|
|
|
(IN THOUSANDS,
EXCEPT SHARE DATA)
|
September
30,
2024
|
|
December 31,
2023
|
ASSETS
|
|
|
|
Current
assets:
|
|
|
|
Cash and cash
equivalents
|
$
57,085
|
|
$ 124,759
|
Restricted
cash
|
170
|
|
54
|
Accounts receivable,
net
|
81,168
|
|
74,609
|
Unbilled
receivables
|
48,421
|
|
46,548
|
Prepaid expenses and
other current assets
|
38,030
|
|
18,959
|
Total current
assets
|
224,874
|
|
264,929
|
Property and equipment,
net
|
4,077
|
|
3,769
|
Internal use software,
net
|
51,546
|
|
40,301
|
Intangible assets,
net
|
150,618
|
|
178,908
|
Goodwill
|
675,538
|
|
675,282
|
Operating lease
right-of-use assets
|
20,472
|
|
21,668
|
Deferred tax asset,
net
|
2,544
|
|
2,465
|
Other long-term
assets
|
5,029
|
|
4,402
|
Total assets
|
$
1,134,698
|
|
$
1,191,724
|
LIABILITIES AND
STOCKHOLDERS' EQUITY
|
|
|
|
Current
liabilities:
|
|
|
|
Accounts payable and
accrued expenses
|
$
48,874
|
|
$
72,232
|
Operating lease
liability
|
10,242
|
|
9,435
|
Due to related
party
|
2
|
|
121
|
Deferred
revenue
|
1,454
|
|
682
|
Total current
liabilities
|
60,572
|
|
82,470
|
Deferred tax liability,
net
|
4,989
|
|
20,367
|
Long-term debt,
net
|
64,073
|
|
153,725
|
Operating lease
liabilities, non-current
|
16,391
|
|
19,523
|
Other long-term
liabilities
|
6,186
|
|
6,183
|
Total
liabilities
|
152,211
|
|
282,268
|
Commitments and
Contingencies (Note 13)
|
|
|
|
Stockholders'
Equity
|
|
|
|
Preferred Stock, $0.001
par value, 50,000,000 shares authorized at September 30,
2024;
0 shares issued and
outstanding at September 30, 2024 and December 31, 2023.
|
-
|
|
-
|
Common Stock, $0.001
par value, 500,000,000 shares authorized, 161,955,151
and
158,757,620 shares
issued and outstanding at September 30, 2024 and December
31,
2023,
respectively.
|
162
|
|
159
|
Additional
paid-in-capital
|
952,123
|
|
901,259
|
Accumulated other
comprehensive loss
|
(1,276)
|
|
(916)
|
Retained
earnings
|
31,478
|
|
8,954
|
Total stockholders'
equity
|
982,487
|
|
909,456
|
Total liabilities and
stockholders' equity
|
$
1,134,698
|
|
$
1,191,724
|
INTEGRAL AD SCIENCE
HOLDING CORP.
|
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(LOSS)
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended September 30,
|
|
Nine Months
Ended September 30,
|
(IN THOUSANDS,
EXCEPT SHARE AND PER SHARE DATA)
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Revenue
|
|
$ 133,528
|
|
$ 120,331
|
|
$ 377,063
|
|
$ 340,074
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
Cost of revenue
(excluding depreciation and amortization
shown below)
|
|
27,373
|
|
25,599
|
|
80,628
|
|
71,100
|
Sales and
marketing
|
|
30,144
|
|
29,604
|
|
91,541
|
|
87,566
|
Technology and
development
|
|
16,840
|
|
17,211
|
|
52,305
|
|
53,850
|
General and
administrative
|
|
25,348
|
|
22,611
|
|
71,407
|
|
85,673
|
Depreciation and
amortization
|
|
16,243
|
|
14,027
|
|
47,032
|
|
40,373
|
Foreign exchange (gain)
loss, net
|
|
(2,607)
|
|
2,078
|
|
(723)
|
|
931
|
Total operating
expenses
|
|
113,341
|
|
111,130
|
|
342,190
|
|
339,493
|
Operating
income
|
|
20,187
|
|
9,201
|
|
34,873
|
|
581
|
Interest expense,
net
|
|
(1,325)
|
|
(3,109)
|
|
(4,787)
|
|
(9,747)
|
Net income (loss)
before income taxes
|
|
18,862
|
|
6,092
|
|
30,086
|
|
(9,166)
|
(Provision) benefit for
income taxes
|
|
(2,773)
|
|
(19,841)
|
|
(7,562)
|
|
6,240
|
Net income
(loss)
|
|
$ 16,089
|
|
$ (13,749)
|
|
$ 22,524
|
|
$
(2,926)
|
Net income (loss) per
share – basic and diluted
|
|
$
0.10
|
|
$
(0.09)
|
|
$
0.14
|
|
$
(0.02)
|
Weighted average shares
outstanding:
|
|
|
|
|
|
|
|
|
Basic
|
|
161,663,506
|
|
157,055,904
|
|
160,528,610
|
|
157,691,005
|
Diluted
|
|
165,084,108
|
|
157,055,904
|
|
164,635,076
|
|
157,691,005
|
Other comprehensive
income (loss):
|
|
|
|
|
|
|
|
|
Foreign
currency translation adjustments
|
|
892
|
|
(1,717)
|
|
(360)
|
|
(789)
|
Total comprehensive
income (loss)
|
|
$ 16,981
|
|
$ (15,466)
|
|
$ 22,164
|
|
$
(3,715)
|
Stock-Based
Compensation
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
September 30,
|
|
Nine Months
Ended
September 30,
|
(IN
THOUSANDS)
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Cost of
revenue
|
$ 80
|
|
$ 118
|
|
$ 286
|
|
$ 328
|
Sales and
marketing
|
4,829
|
|
5,714
|
|
14,002
|
|
17,859
|
Technology and
development
|
4,941
|
|
2,902
|
|
14,139
|
|
13,434
|
General and
administrative
|
6,593
|
|
5,166
|
|
18,758
|
|
34,020
|
Total stock-based
compensation
|
$16,443
|
|
$13,900
|
|
$47,185
|
|
$65,641
|
INTEGRAL AD SCIENCE
HOLDING CORP.
|
CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS'
EQUITY
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30,
2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common
Stock
|
|
|
|
|
|
|
|
|
|
(IN THOUSANDS,
EXCEPT SHARES)
|
|
Shares
|
|
Amount
|
|
Additional
paid-in
capital
|
|
Accumulated
other
comprehensive
loss
|
|
Retained
earnings
|
|
|
Total
stockholders'
equity
|
Balance, June 30,
2024
|
|
160,786,740
|
|
$
161
|
|
$934,194
|
|
$
(2,168)
|
|
$
15,389
|
|
|
$ 947,576
|
RSUs and MSUs
vested
|
|
995,796
|
|
1
|
|
-
|
|
-
|
|
-
|
|
|
1
|
ESPP
purchase
|
|
172,615
|
|
-
|
|
1,478
|
|
-
|
|
-
|
|
|
1,478
|
Stock-based
compensation
|
|
-
|
|
-
|
|
16,451
|
|
-
|
|
-
|
|
|
16,451
|
Foreign currency
translation adjustment
|
|
-
|
|
-
|
|
-
|
|
892
|
|
-
|
|
|
892
|
Net income
|
|
-
|
|
-
|
|
-
|
|
-
|
|
16,089
|
|
|
16,089
|
Balance, September
30, 2024
|
|
161,955,151
|
|
$
162
|
|
$952,123
|
|
$
(1,276)
|
|
$
31,478
|
|
|
$ 982,487
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30,
2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common
Stock
|
|
|
|
|
|
|
|
|
|
(IN THOUSANDS,
EXCEPT SHARES)
|
|
Shares
|
|
Amount
|
|
Additional
paid-in
capital
|
|
Accumulated
other
comprehensive
loss
|
|
Retained
earnings
|
|
|
Total
stockholders'
equity
|
Balance, December
31, 2023
|
|
158,757,620
|
|
$
159
|
|
$901,259
|
|
$
(916)
|
|
$
8,954
|
|
|
$ 909,456
|
RSUs and MSUs
vested
|
|
2,827,628
|
|
3
|
|
-
|
|
-
|
|
-
|
|
|
3
|
Option
exercises
|
|
44,049
|
|
-
|
|
313
|
|
-
|
|
-
|
|
|
313
|
ESPP
purchase
|
|
325,854
|
|
-
|
|
3,373
|
|
-
|
|
-
|
|
|
3,373
|
Stock-based
compensation
|
|
-
|
|
-
|
|
47,178
|
|
-
|
|
-
|
|
|
47,178
|
Foreign currency
translation adjustment
|
|
-
|
|
-
|
|
-
|
|
(360)
|
|
-
|
|
|
(360)
|
Net income
|
|
-
|
|
-
|
|
-
|
|
-
|
|
22,524
|
|
|
22,524
|
Balance, September
30, 2024
|
|
161,955,151
|
|
$
162
|
|
$952,123
|
|
$
(1,276)
|
|
$
31,478
|
|
|
$ 982,487
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30,
2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common
Stock
|
|
|
|
|
|
|
|
|
|
(IN THOUSANDS,
EXCEPT SHARES)
|
|
Shares
|
|
Amount
|
|
Additional
paid-in
capital
|
|
Accumulated
other
comprehensive
loss
|
|
Retained
earnings
(accumulated
deficit)
|
|
|
Total
stockholders'
equity
|
Balance, June 30,
2023
|
|
156,279,075
|
|
$
156
|
|
$867,490
|
|
$
(1,971)
|
|
$
12,539
|
|
|
$ 878,214
|
RSUs and MSUs
vested
|
|
1,102,702
|
|
1
|
|
-
|
|
-
|
|
-
|
|
|
1
|
Option
exercises
|
|
53,748
|
|
1
|
|
590
|
|
-
|
|
-
|
|
|
591
|
ESPP
purchase
|
|
162,406
|
|
-
|
|
1,424
|
|
-
|
|
-
|
|
|
1,424
|
Stock-based
compensation
|
|
-
|
|
-
|
|
13,882
|
|
-
|
|
-
|
|
|
13,882
|
Foreign currency
translation adjustment
|
|
-
|
|
-
|
|
-
|
|
(1,717)
|
|
-
|
|
|
(1,717)
|
Net loss
|
|
-
|
|
-
|
|
-
|
|
-
|
|
(13,749)
|
|
|
(13,749)
|
Balance, September
30, 2023
|
|
157,597,931
|
|
$
158
|
|
$883,386
|
|
$
(3,688)
|
|
$
(1,210)
|
|
|
$ 878,646
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30,
2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common
Stock
|
|
|
|
|
|
|
|
|
|
(IN THOUSANDS,
EXCEPT SHARES)
|
|
Shares
|
|
Amount
|
|
Additional
paid-in
capital
|
|
Accumulated
other
comprehensive
loss
|
|
Retained
earnings
(accumulated
deficit)
|
|
|
Total
stockholders'
equity
|
Balance, December
31, 2022
|
|
153,990,128
|
|
$
154
|
|
$810,186
|
|
$
(2,899)
|
|
$
775
|
|
|
$ 808,216
|
RSUs and MSUs
vested
|
|
2,692,984
|
|
3
|
|
-
|
|
-
|
|
-
|
|
|
3
|
Option
exercises
|
|
641,250
|
|
1
|
|
5,583
|
|
-
|
|
-
|
|
|
5,584
|
ESPP
purchase
|
|
273,569
|
|
-
|
|
2,306
|
|
-
|
|
-
|
|
|
2,306
|
Stock-based
compensation
|
|
-
|
|
-
|
|
65,311
|
|
-
|
|
-
|
|
|
65,311
|
Foreign currency
translation adjustment
|
|
-
|
|
-
|
|
-
|
|
(789)
|
|
-
|
|
|
(789)
|
Adoption of ASC 326,
net of tax
|
|
-
|
|
-
|
|
-
|
|
-
|
|
941
|
|
|
941
|
Net loss
|
|
-
|
|
-
|
|
-
|
|
-
|
|
(2,926)
|
|
|
(2,926)
|
Balance, September
30, 2023
|
|
157,597,931
|
|
$
158
|
|
$883,386
|
|
$
(3,688)
|
|
$
(1,210)
|
|
|
$ 878,646
|
INTEGRAL AD SCIENCE
HOLDING CORP.
|
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
(UNAUDITED)
|
|
|
|
|
|
|
|
Nine Months
Ended September 30,
|
(IN
THOUSANDS)
|
|
2024
|
|
2023
|
Cash flows from
operating activities:
|
|
|
|
|
Net income
(loss)
|
|
$22,524
|
|
$
(2,926)
|
Adjustments to
reconcile net income (loss) to net cash provided by operating
activities:
|
|
|
|
|
Depreciation and
amortization
|
|
47,032
|
|
40,373
|
Stock-based
compensation
|
|
47,185
|
|
65,641
|
Foreign currency (gain)
loss, net
|
|
(1,775)
|
|
571
|
Deferred tax
benefit
|
|
(15,457)
|
|
(17,974)
|
Amortization of debt
issuance costs
|
|
348
|
|
348
|
Allowance for credit
losses
|
|
949
|
|
2,223
|
Impairment of
assets
|
|
37
|
|
-
|
Changes in operating
assets and liabilities:
|
|
|
|
|
Increase in accounts
receivable
|
|
(7,028)
|
|
(19,936)
|
Increase in unbilled
receivables
|
|
(1,723)
|
|
(370)
|
(Increase) decrease in
prepaid expenses and other current assets
|
|
(18,668)
|
|
5,851
|
(Increase) decrease in
operating leases, net
|
|
(1,169)
|
|
139
|
Increase in other
long-term assets
|
|
(696)
|
|
(27)
|
(Decrease) increase in
accounts payable and accrued expenses and other long-term
liabilities
|
|
(21,958)
|
|
148
|
Increase in deferred
revenue
|
|
768
|
|
150
|
Decrease in due to/from
related party
|
|
(119)
|
|
(93)
|
Net cash provided by
operating activities
|
|
50,250
|
|
74,118
|
Cash flows from
investing activities:
|
|
|
|
|
Purchase of property
and equipment
|
|
(1,594)
|
|
(1,954)
|
Development of internal
use software and other
|
|
(28,868)
|
|
(23,539)
|
Net cash used in
investing activities
|
|
(30,462)
|
|
(25,493)
|
Cash flows from
financing activities:
|
|
|
|
|
Proceeds from the
Revolver
|
|
-
|
|
75,000
|
Repayment of long-term
debt
|
|
(90,000)
|
|
(125,000)
|
Proceeds from exercise
of stock options
|
|
313
|
|
5,584
|
Cash received from
Employee Stock Purchase Program
|
|
2,329
|
|
2,236
|
Net cash used in
financing activities
|
|
(87,358)
|
|
(42,180)
|
Net (decrease) increase
in cash, cash equivalents, and restricted cash
|
|
(67,570)
|
|
6,445
|
Effect of exchange rate
changes on cash, cash equivalents and restricted cash
|
|
(113)
|
|
(1,330)
|
Cash, cash equivalents
and restricted cash at beginning of period
|
|
127,290
|
|
89,671
|
Cash, cash
equivalents, and restricted cash, at end of period
|
|
$59,607
|
|
$ 94,786
|
Supplemental
Disclosures:
|
|
|
|
|
Net cash paid during
the period for:
|
|
|
|
|
Interest
|
|
$
4,613
|
|
$
8,880
|
Taxes
|
|
$29,942
|
|
$ 10,361
|
Non-cash investing and
financing activities:
|
|
|
|
|
Property and equipment
acquired included in accounts payable
|
|
$ 47
|
|
$
17
|
Internal use software
acquired included in accounts payable
|
|
$ 966
|
|
$
1,012
|
Lease liabilities
arising from right of use assets
|
|
$
6,110
|
|
$
4,832
|
Supplemental Disclosure Regarding Non-GAAP Financial
Information
We use supplemental measures of our performance, which are
derived from our consolidated financial information, but which are
not presented in our consolidated financial statements prepared in
accordance with GAAP. Adjusted EBITDA is the primary financial
performance measure used by management to evaluate our business and
monitor ongoing results of operations. Adjusted EBITDA is defined
as income before depreciation and amortization, stock-based
compensation, interest expense, income taxes, acquisition,
restructuring and integration costs, foreign exchange gain, net,
asset impairments, and other one-time, non-recurring costs.
Adjusted EBITDA margin represents the adjusted EBITDA for the
applicable period divided by the revenue for that period presented
in accordance with GAAP.
We use non-GAAP financial measures to supplement financial
information presented on a GAAP basis. We believe that excluding
certain items from our GAAP results allows management to better
understand our consolidated financial performance from period to
period and better project our future consolidated financial
performance as forecasts are developed at a level of detail
different from that used to prepare GAAP-based financial measures.
Moreover, we believe these non-GAAP financial measures provide our
shareholders with useful information to help them evaluate our
operating results by facilitating an enhanced understanding of our
operating performance and enabling them to make more meaningful
period-to-period comparisons. Although we believe these measures
are useful to investors and analysts for the same reasons they are
useful to management, as discussed below, these measures are not a
substitute for, or superior to, U.S. GAAP financial measures or
disclosures. Our non-GAAP financial measures may not be comparable
to similarly titled measures of other companies. Other companies,
including companies in our industry, may calculate non-GAAP
financial measures differently than we do, limiting the usefulness
of those measures for comparative purposes.
Reconciliations of historical adjusted EBITDA to its most
directly comparable GAAP financial measure, net income/loss, are
presented below. We encourage you to review the reconciliations in
conjunction with the presentation of the non-GAAP financial
measures for each of the periods presented. In future fiscal
periods, we may exclude such items and may incur income and
expenses similar to these excluded items.
Reconciliation of
Adjusted EBITDA
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
September 30,
|
|
Nine Months
Ended
September 30,
|
(IN THOUSANDS,
EXCEPT PERCENTAGES)
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net income
(loss)
|
|
$
16,089
|
|
$(13,749)
|
|
$
22,524
|
|
$
(2,926)
|
Depreciation and
amortization
|
|
16,243
|
|
14,027
|
|
47,032
|
|
40,373
|
Stock-based
compensation
|
|
16,443
|
|
13,900
|
|
47,185
|
|
65,641
|
Interest expense,
net
|
|
1,325
|
|
3,109
|
|
4,787
|
|
9,747
|
Provision (benefit) for
income taxes
|
|
2,773
|
|
19,841
|
|
7,562
|
|
(6,240)
|
Acquisition,
restructuring and integration costs
|
|
290
|
|
1,353
|
|
1,465
|
|
2,974
|
Foreign exchange (gain)
loss, net
|
|
(2,607)
|
|
2,078
|
|
(723)
|
|
931
|
Asset impairments and
other costs
|
|
90
|
|
11
|
|
90
|
|
1,517
|
Adjusted
EBITDA
|
|
$
50,646
|
|
$
40,570
|
|
$129,922
|
|
$112,017
|
Revenue
|
|
$133,528
|
|
$120,331
|
|
$377,063
|
|
$340,074
|
Net income (loss)
margin
|
|
12 %
|
|
(11) %
|
|
6 %
|
|
(1) %
|
Adjusted EBITDA
margin
|
|
38 %
|
|
34 %
|
|
34 %
|
|
33 %
|
Conference Call and Webcast Information
IAS will host
a conference call and live webcast to discuss its third quarter
2024 financial results today at 5:00 p.m.
ET. To access the live webcast and conference call dial-in,
please register under the "News & Events" section of IAS's
investor relations website. A replay will be available on IAS's
investor relations website following the live call:
https://investors.integralads.com.
About Integral Ad Science
Integral Ad Science (IAS) is
a leading global media measurement and optimization platform that
delivers the industry's most actionable data to drive superior
results for the world's largest advertisers, publishers, and media
platforms. IAS's software provides comprehensive and enriched data
that ensures ads are seen by real people in safe and suitable
environments, while improving return on ad spend for advertisers
and yield for publishers. Our mission is to be the global benchmark
for trust and transparency in digital media quality. For more
information, visit integralads.com.
Forward-Looking Statements
This earnings press release
contains forward-looking statements that are subject to risks and
uncertainties. All statements other than statements of historical
fact included in this press release are forward-looking statements.
Forward-looking statements give our current expectations and
projections relating to our financial condition, results of
operations, plans, objectives, future performance, including
guidance, and business, including pipeline and industry trends. You
can identify forward-looking statements by the fact that they do
not relate strictly to historical or current facts. These
statements may include words such as "anticipate," "estimate,"
"expect," "project," "plan," "intend," "believe," "may," "will,"
"should," "can have," "likely," and other words and terms of
similar meaning in connection with any discussion of the timing or
nature of future operating or financial performance or other
events. For example, all statements we make relating to our
estimated and projected costs, profitability, expenditures, cash
flows, growth rates and financial results or our plans and
objectives for future operations, growth initiatives or strategies,
including pursuing business from Oracle or other competitors are
forward-looking statements. All forward-looking statements are
subject to risks and uncertainties that may cause actual results to
differ materially from those that we expected, including: (i) the
adverse effect on our business, operating results, financial
condition, and prospects from various macroeconomic factors,
including instability in geopolitical or market conditions; (ii)
our failure to innovate or make the right investment decisions;
(iii) our ability to provide digital or cross-platform analytics;
(iv) our failure to maintain or achieve industry accreditation
standards; (v) our dependence on integrations with advertising
platforms, demand side providers ("DSPs") and proprietary platforms
that we do not control; (vi) our ability to compete successfully
with our current or future competitors in an intensely competitive
market, including with respect to the Oracle opportunity; (vii) our
inability to use software licensed from third parties; (viii) our
international expansion; (ix) our ability to expand into new
channels; (x) our ability to sustain our profitability and revenue
growth rate; (xi) risks that our customers do not pay or choose to
dispute their invoices; (xii) risks of material changes to revenue
share agreements with certain DSPs; (xiii) our dependence on the
overall demand for advertising; (xiv) our ability to effectively
manage our growth; (xv) the impact that any acquisitions we have
completed in the past and may consummate in the future, strategic
investments, or alliances may have on our business, financial
condition, and results of operations; (xvi) our ability to
successfully execute our international plans; (xvii) the risks
associated with the seasonality of our market; (xviii) our ability
to maintain high impression volumes; (xix) the difficulty in
evaluating our future prospects given our short operating history;
(xx) uncertainty in how the market for buying digital advertising
verification solutions will evolve; (xxi) interruption by man-made
problems such as terrorism, computer viruses, or social
disruptions; (xxii) the risk of failures in the systems and
infrastructure supporting our solutions and operations; (xxiii) our
ability to avoid operational, technical, and performance issues
with our platform; (xxiv) risks associated with any unauthorized
access to user, customer, or inventory and third-party provider
data; (xxv) our ability to provide the non-proprietary technology,
software, products, and services that we use; (xxvi) the risk that
we are sued by third parties for alleged infringement,
misappropriation, or other violation of their proprietary rights;
(xxvii) our ability to obtain, maintain, protect, or enforce
intellectual property and proprietary rights that are important to
our business; (xxviii) our involvement in lawsuits to protect or
enforce our intellectual property; (xxix) risks that our employees,
consultants, or advisors have wrongfully used or disclosed
alleged trade secrets of their current or former
employers; (xxx) risks that our trademarks and trade names are not
adequately protected; (xxxi) the impact of unforeseen changes to
privacy and data protection laws and regulation on digital
advertising; (xxxii) our ability to maintain our corporate culture;
(xxxiii) public health outbreaks, epidemics, pandemics, or other
public health crises; (xxxiv) risks posed by earthquakes, fires,
floods, and other natural catastrophic events; (xxxv) the risk that
a perceived failure to comply with laws and industry
self-regulation may damage our reputation; and (xxxvi) other
factors disclosed in our filings with the SEC. Given these factors,
as well as other variables that may affect our operating results,
you should not rely on forward-looking statements, assume that past
financial performance will be a reliable indicator of future
performance, or use historical trends to anticipate results or
trends in future periods.
We derive many of our forward-looking statements from our
operating budgets and forecasts, which are based on many detailed
assumptions. While we believe that our assumptions are reasonable,
we caution that it is very difficult to predict the impact of known
factors, and it is impossible for us to anticipate all factors that
could affect our actual results. The forward-looking statements
included in this press release are made only as of the date hereof.
We undertake no obligation to update or revise any forward- looking
statement as a result of new information, future events or
otherwise, except as otherwise required by law.
Investor Contact:
Jonathan
Schaffer
ir@integralads.com
Media Contact:
press@integralads.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ias-reports-third-quarter-2024-financial-results-302303120.html
SOURCE Integral Ad Science, Inc.